158 related articles for article (PubMed ID: 18377389)
1. Serotonin toxicity.
Gillman K
Headache; 2008 Apr; 48(4):640-1. PubMed ID: 18377389
[No Abstract] [Full Text] [Related]
2. Triptans and serotonin syndrome.
Evans RW
Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
[No Abstract] [Full Text] [Related]
3. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
Bonetto N; Santelli L; Battistin L; Cagnin A
Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
[No Abstract] [Full Text] [Related]
4. Serotonin syndrome: a reported case.
Avarello TP; Cottone S
Neurol Sci; 2002 Sep; 23 Suppl 2():S55-6. PubMed ID: 12548341
[TBL] [Abstract][Full Text] [Related]
5. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
Evans RW
Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
[No Abstract] [Full Text] [Related]
6. Drug-Induced Serotonin Syndrome.
Bartlett D
Crit Care Nurse; 2017 Feb; 37(1):49-54. PubMed ID: 28148614
[TBL] [Abstract][Full Text] [Related]
7. Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.
Rosenbaum HK; Gillman PK
A A Case Rep; 2016 Jul; 7(1):1. PubMed ID: 27415030
[No Abstract] [Full Text] [Related]
8. The serotonin syndrome.
Bijl D
Neth J Med; 2004 Oct; 62(9):309-13. PubMed ID: 15635814
[TBL] [Abstract][Full Text] [Related]
9. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.
Gillman PK
J Psychopharmacol; 2011 Mar; 25(3):429-36. PubMed ID: 20142303
[TBL] [Abstract][Full Text] [Related]
10. [Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].
Güzelcan Y; Kleinpenning AS
Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1748; author reply 1748-9. PubMed ID: 16927475
[No Abstract] [Full Text] [Related]
11. Serotonin syndrome resulting from drug interactions.
Chan BS; Graudins A; Whyte IM; Dawson AH; Braitberg G; Duggin GG
Med J Aust; 1998 Nov; 169(10):523-5. PubMed ID: 9861909
[TBL] [Abstract][Full Text] [Related]
12. eComment: Serotonin syndrome: pharmacogenomics and treatment.
Koniari I; Tsigkas G; Apostolakis E
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):657-8. PubMed ID: 18664669
[No Abstract] [Full Text] [Related]
13. [The serotoninergic syndrome: moclobemide and citalopram].
Gumà M; Clemente F; Segura A; Costa J
Med Clin (Barc); 1999 Nov; 113(17):677-8. PubMed ID: 10618787
[No Abstract] [Full Text] [Related]
14. Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.
Hébant B; Guillaume M; Desbordes M; Gaillon G; Maltête D; Lefaucheur R
Rev Neurol (Paris); 2016 Dec; 172(12):788-789. PubMed ID: 27838092
[No Abstract] [Full Text] [Related]
15. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.
Jimenez-Genchi A
J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070
[No Abstract] [Full Text] [Related]
16. Triptans and serotonin syndrome.
Fine A; Bastings E
Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
[No Abstract] [Full Text] [Related]
17. Triptans, SSRIs/SNRIs and serotonin syndrome.
Rothrock JF
Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
[No Abstract] [Full Text] [Related]
18. Serotonin syndrome with moclobemide-fluoxetine combination.
Benazzi F
Pharmacopsychiatry; 1996 Jul; 29(4):162. PubMed ID: 8858717
[No Abstract] [Full Text] [Related]
19. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
Tepper SJ
Headache; 2012 Feb; 52(2):195-7. PubMed ID: 22221260
[No Abstract] [Full Text] [Related]
20. Serotonin syndrome cause and treatment.
Reynolds RD
J Am Board Fam Pract; 1996; 9(1):73-4. PubMed ID: 8770822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
